0 CHECKOUT

Analgesics - Brazil

  • ID: 1543067
  • February 2011
  • Region: Brazil
  • 49 pages
  • Euromonitor International
1 of 3

2009 was marked by swine flu, which contributed to maintaining strong sales in that year. In 2010, analgesics continued to show robust growth driven by rising disposable income, especially amongst lower-income consumers, who had limited access to medicines in Brazil. According to Euromonitor International estimates, households with monthly disposable income over US$750 increased from 31.1% in 2005 to 46.8% in 2010.

The Analgesics in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2006-2010, allowing you to identify the sectors driving growth. Forecasts to 2015 illustrate how the market is set to change.

Product coverage: Acne Treatments, Allergy Eye Care, Antihistamines/Allergy Remedies (Systemic), Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Child-Specific Cough, Cold and Allergy Remedies, Child-Specific Digestive Remedies, Child-Specific Medicated Skin Care, Cold Sore Treatments, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Diarrhoeal Remedies, First Aid Kits, Gauze, Tape and Other Wound Care, Haemorrhoid READ MORE >

Note: Product cover images may vary from those shown
2 of 3

Analgesics in Brazil
Euromonitor International
February 2011
List of Contents and Tables
Executive Summary
Consumer Health Shows Double-digit Growth in 2010
Approval of Tracking System for Medicines
Further Acquisitions
Direct Selling and Internet Retailing Slowly Increase Sales
Positive Outlook for Consumer Health
Key Trends and Developments
Further Acquisitions in Pharmaceutical Market
Growing Disposable Income Stimulates Consumer Health
Low Presence of Generics in OTC
Investment in the Tracking System of Medicines
Advances in Herbal/traditional Products Regulation
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
Table 2 Life Expectancy at Birth 2005-2010
Market Data
Table 3 Sales of Consumer Health by Category: Value 2005-2010
Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
Table 5 Consumer Health Company Shares by Value 2006-2010
Table 6 Consumer Health Brand Shares by Value 2007-2010
Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015
Appendix
OTC Registration and Classification
De-reimbursement
Generics
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 Consumer Health Switches 2008-2010
Definitions
Summary 2 Research Sources
Aché Laboratórios Farmacêuticos SA
Strategic Direction
Key Facts
Summary 3 Aché Laboratórios Farmacêuticos SA: Key Facts
Summary 4 Aché Laboratórios Farmacêuticos SA: Operational Indicators
Company Background
Production
Summary 5 Aché Laboratórios Farmacêuticos SA: Production Statistics 2010
Competitive Positioning
Summary 6 Aché Laboratórios Farmacêuticos SA: Competitive Position 2010
Bayer (brasil) SA
Strategic Direction
Key Facts
Summary 7 Bayer SA: Key Facts
Summary 8 Bayer SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 9 Bayer SA: Competitive Position 2010
Boehringer Ingelheim Do Brasil Química E Farmacêutica Ltda
Strategic Direction
Key Facts
Summary 10 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Key Facts
Summary 11 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Operational Indicators
Company Background
Production
Summary 12 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Production Statistics 2010
Competitive Positioning
Summary 13 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Competitive Position 2010
Cadbury Adams Brasil Indústria E Comércio De Produtos Alimentícios Ltda
Strategic Direction
Key Facts
Summary 14 Cadbury Adams Indústria e Comércio Alimentícios Ltda: Key Facts
Summary 15 Cadbury Adams Indústria e Comércio Alimentícios Ltda: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 16 Cadbury Adams Indústria e Comércio Alimentícios Ltda: Competitive Position 2010
Ems SA
Strategic Direction
Key Facts
Summary 17 EMS SA: Key Facts
Summary 18 EMS SA: Operational Indicators
Company Background
Production
Summary 19 EMS SA: Production Statistics 2010
Competitive Positioning
Summary 20 EMS SA: Competitive Position 2010
Eurofarma Laboratório Ltda
Strategic Direction
Key Facts
Summary 21 Eurofarma Laboratório Ltda: Key Facts
Summary 22 Eurofarma Laboratório Ltda: Operational Indicators
Company Background
Production
Summary 23 Eurofarma Laboratório Ltda: Production Statistics 2010
Competitive Positioning
Summary 24 Eurofarma Laboratório Ltda: Competitive Position 2010
Hypermarcas SA
Strategic Direction
Key Facts
Summary 25 Hypermarcas SA: Key Facts
Summary 26 Hypermarcas SA: Operational Indicators
Company Background
Production
Summary 27 Hypermarcas SA: Production Statistics 2010
Competitive Positioning
Summary 28 Hypermarcas SA: Competitive Position 2010
Medley SA Indústria Farmacêutica
Strategic Direction
Key Facts
Summary 29 Medley SA Indústria Farmacêutica: Key Facts
Summary 30 Medley SA Indústria Farmacêutica: Operational Indicators
Company Background
Production
Summary 31 Medley SA Indústria Farmacêutica: Production Statistics 2010
Competitive Positioning
Summary 32 Medley SA Indústria Farmacêutica: Competitive Position 2010
Nycomed Pharma Ltda
Strategic Direction
Key Facts
Summary 33 Nycomed Pharma Ltda: Key Facts
Summary 34 Nycomed Pharma Ltda: Operational Indicators
Company Background
Production
Summary 35 Nycomed Pharma Ltda: Production Statistics 2010
Competitive Positioning
Summary 36 Nycomed Pharma Ltda: Competitive Position 2010
Sanofi-aventis Farmacêutica Ltda
Strategic Direction
Key Facts
Summary 37 Sanofi-Aventis Farmacêutica Ltda: Key Facts
Summary 38 Sanofi-Aventis Farmacêutica Ltda: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 39 Sanofi-Aventis Farmacêutica Ltda: Competitive Position 2010
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 11 Sales of Analgesics by Category: Value 2005-2010
Table 12 Sales of Analgesics by Category: % Value Growth 2005-2010
Table 13 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
Table 14 Analgesics Company Shares by Value 2006-2010
Table 15 Analgesics Brand Shares by Value 2007-2010
Table 16 Forecast Sales of Analgesics by Category: Value 2010-2015
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Baxter International Inc.
  • Endo International Plc.
  • Medtronic, Inc.
  • Johnson & Johnson Services, Inc.
  • Procter & Gamble Co.
  • Purdue Pharma L.P.